Lonza Group AG


in

Lonza Group AG entered into a strategic partnership with Sanofi Pasteur in the area of cell culture vaccine production. The two parties have signed a technical service agreement related to the new cell-based influenza vaccine developed by sanofi pasteur. Under the agreement Lonza will provide sanofi pasteur with its expertise in mammalian cell culture operations.